Blunted Cortisol Awakening Response in People at Ultra High Risk of Developing Psychosis

Schizophrenia Research

Volumn 158, Issue 1-3, 2014, Pages 25-31

  Day, Fern L ^a,b   Valmaggia, Lucia R ^a,b   Mondelli, Valeria ^a   Papadopoulos, Andrew ^a,c   Papadopoulos, Irene ^a,c   Pariante, Carmine M ^a   McGuire, Philip ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c BETHLEM ROYAL HOSPITAL   (United Kingdom)

Author keywords

At Risk Mental State; Cortisol; HPA axis; Psychosis; Schizophrenia; Ultra High Risk

Indexed keywords

ANTACID AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; ANXIOLYTIC AGENT; HYDROCORTISONE; MOOD STABILIZER; NEUROLEPTIC AGENT; STEROID;

ADULT; AROUSAL; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CORTISOL AWAKENING RESPONSE; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE COURSE; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HEBEPHRENIA; HIGH RISK PATIENT; HORMONE RESPONSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; RISK; RISK ASSESSMENT; SALIVA LEVEL; SOCIAL CLASS; STEROID RELEASE; STRESS; ULTRA HIGH RISK; CIRCADIAN RHYTHM; DISEASE PREDISPOSITION; METABOLISM; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOTIC DISORDERS; SALIVA; WAKEFULNESS; YOUNG ADULT;

CIRCADIAN RHYTHM; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; HYDROCORTISONE; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK; SALIVA; WAKEFULNESS; YOUNG ADULT;

EID: 84906937657     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.06.041     Document Type: Article

References (35)

1. Aiello G., Horowitz M., Hepgul N., Pariante C.M., Mondelli V. Stress abnormalities in individuals at risk for psychosis: A review of studies in subjects with familial risk or with "at risk" mental state. Psychoneuroendocrinology 2012, 37(10):1600-1613.
2. Babson A.L. Unitised reagent random access analysers - Immulite. The Immunoassay Handbook 2001, Nature Publishing Group, London. 2nd revised ed. D.G. Wild (Ed.).
3. Bebbington P., Wilkins S., Jones P., Foerster A., Murray R., Toone B., Lewis S. Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study. Br. J. Psychiatry 1993, 162:72-79.
4. Beck A.T., Steer R.A., Brown G. Manual for the Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio, TX.
5. Belvederi Murri M., Pariante C.M., Dazzan P., Hepgul N., Papadopoulos A.S., Zunszain P., Di Forti M., Murray R.M., Mondelli V. Hypothalamic-pituitary-adrenal axis and clinical symptoms in first-episode psychosis. Psychoneuroendocrinology 2012, 37(5):629-644.
6. Brewer W.J., Wood S.J., Phillips L.J., Francey S.M., Pantelis C., Yung A.R., Cornblatt B., McGorry P.D. Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr. Bull. 2006, 32(3):538-555.
7. Clow A., Thorn L., Evans P., Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress 2004, 7(1):29-37.
8. Corcoran C., Walker E., Huot R., Mittal V., Tessner K., Kestler L., Malaspina D. The Stress Cascade and Schizophrenia: Etiology and Onset. Schizophr. Bull. 2003, 29(4):671-692.
9. Corcoran C.M., Smith C., McLaughlin D., Auther A., Malaspina D., Cornblatt B. HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia. Schizophr. Res. 2012, 135(1):170-174.
10. Fries E., Dettenborn L., Kirschbaum C. The cortisol awakening response (CAR): Facts and future directions. Int. J. Psychophysiol. 2009, 72:67-73.
11. Fusar-Poli P., Bonoldi I., Yung A.R., Borgwardt S., Kempton M.J., Valmaggia L., Barale F., Caverzasi E., McGuire P. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch. Gen. Psychiatry 2012, 69(3):220-229.
12. Fusar-Poli P., Byrne M., Badger S., Valmaggia L.R., McGuire P.K. Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. Eur. Psychiatry 2013, 28(5):315-326.
13. Garde A.H., Hansen A.M. Long-term stability of salivary cortisol. Scand. J. Clin. Lab. Invest. 2005, 65:433-436.
14. Garner B., Pariante C.M., Wood S.J., Velakoulis D., Phillips L., Soulsby B., Brewer W.J., Smith D.J., Dazzan P., Berger G.E., Yung A.R., van den Buuse M., Murray R., McGorry P.D., Pantelis C. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol. Psychiatry 2005, 58(5):417-423.
15. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988, 75:800-802.
16. Howes O.D., Montgomery A.J., Asselin M.C., Murray R.M., Valli I., Tabraham P., Bramon-Bosch E., Valmaggia L., Johns L., Broome M., McGuire P.K., Grasby P.M. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch. Gen. Psychiatry 2009, 66(1):13-20.
17. Kupper N., de Geus E.J., van den Berg M., Kirschbaum C., Boomsma D.I., Willemsen G. Familial influences on basal salivary cortisol in an adult population. Psychoneuroendocrinology 2005, 30(9):857-868.
18. Lataster T., Valmaggia L., Lardinois M., van Os J., Myin-Germeys I. Increased stress reactivity: a mechanism specifically associated with the positive symptoms of psychotic disorder. Psychol. Med. 2013, 43(7):1389-1400.
19. Loewy R.L., Bearden C.E., Johnson J.K., Raine A., Cannon T.D. The prodromal questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes. Schizophr. Res. 2005, 79(1):117-125.
20. Mondelli V., Dazzan P., Hepgul N., Di Forti M., Aas M., D'Albenzio A., Di Nicola M., Fisher H., Handley R., Marques T.R., Morgan C., Navari S., Taylor H., Papadopoulos A., Aitchison K.J., Murray R.M., Pariante C.M. Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment. Schizophr. Res. 2010, 116(2):234-242.
21. Morgan C., Fisher H. Environment and schizophrenia: environmental factors in schizophrenia: childhood trauma-a critical review. Schizophr. Bull. 2007, 33(1):3-10.
22. Pantelis C., Velakoulis D., Wood S.J., Yucel M., Yung A.R., Phillips L.J., Sun D.Q., McGorry P.D. Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int. Rev. Psychiatry 2007, 19(4):371-381.
23. Phassouliotis C., Garner B.A., Phillips L.J., Bendall S., Yun Y., Markulev C., Kerr M., McGorry P.D. Enhanced cortisol suppression following administration of low-dose dexamethasone in first-episode psychosis patients. Aust. N. Z. J. Psychiatry 2013, 47(4):363-370.
24. Pruessner J.C., Kirschbaum C., Meinlschmid G., Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003, 28(7):916-931.
25. Pruessner M., Béchard-Evans L., Boekestyn L., Iyer S.N., Pruessner J.C., Malla A.K. Attenuated cortisol response to acute psychosocial stress in individuals at ultra-high risk for psychosis. Schizophr. Res. 2013, 146(1):79-86.
26. Pruessner M., Vracotas N., Joober R., Pruessner J.C., Malla A.K. Blunted cortisol awakening response in men with first episode psychosis: Relationship to parental bonding. Psychoneuroendocrinology 2013, 38(2):229-240.
27. Schmidt-Reinwald A., Pruessner J.C., Hellhammer D.H., Federenko I., Rohleder N., Schurmeyer T.H., Kirschbaum C. The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm. Life Sci. 1999, 64(18):1653-1660.
28. Varese F., Smeets F., Drukker M., Lieverse R., Lataster T., Viechtbauer W., Read J., van Os J., Bentall R.P. Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr. Bull. 2012, 38(4):661-671.
29. Walker E.F., Diforio D. Schizophrenia: a neural diathesis-stress model. Psychol. Rev. 1997, 104(4):667-685.
30. Walker E., Mittal V., Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu. Rev. Clin. Psychol. 2008, 4:189-216.
31. Walker E.F., Trotman H.D., Pearce B.D., Addington J., Cadenhead K.S., Cornblatt B.A., Heinssen R., Mathalon D.H., Perkins D.O., Seidman L.J., Tsuang M.T., Cannon T.D., McGlashan T.H., Woods S.W. Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study. Biol. Psychiatry 2013, 74(6):410-417. Sep. 15.
32. Wood S.J., Yucel M., Yung A.R., Berger G.E., Velakoulis D., Pantelis C. The transition to psychosis: risk factors and brain changes. Epidemiol. Psychiatr. Soc. 2004, 13(3):137-140.
33. Wust S., Wolf J., Hellhammer D.H., Federenko I., Schommer N., Kirschbaum C. The cortisol awakening response - normal values and confounds. Noise Health 2000, 2(7):79-88.
34. Yung A.R., Phillips L.J., McGorry P.D., McFarlane C.A., Francey S., Harrigan S., Patton G.C., Jackson H.J. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br. J. Psychiatry Suppl. 1998, 172(33):14-20.
35. Yung A.R., Yuen H.P., McGorry P.D., Phillips L.J., Kelly D., Dell'Olio M., Francey S.M., Cosgrave E.M., Killackey E., Stanford C., Godfrey K., Buckby J. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust. N. Z. J. Psychiatr. 2005, 39(11-12):964-971.